{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:26:17Z","timestamp":1793733977643,"version":"4.6.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Nano-immunotherapy improves breast cancer outcomes but not all patients respond and none are cured. To improve efficacy, research focuses on drugs that reprogram cancer-associated fibroblasts (CAFs) to improve therapeutic delivery and immunostimulation. These drugs, however, have a narrow therapeutic window and cause adverse effects. Developing strategies that increase CAF-reprogramming while limiting adverse effects is urgent. Here, taking advantage of the CAF-reprogramming capabilities of tranilast, we developed tranilast-loaded micelles. Strikingly, a 100-fold reduced dose of tranilast-micelles induces superior reprogramming compared to free drug owing to enhanced intratumoral accumulation and cancer-associated fibroblast uptake. Combination of tranilast-micelles and epirubicin-micelles or Doxil with immunotherapy increases T-cell infiltration, resulting in cures and immunological memory in mice bearing immunotherapy-resistant breast cancer. Furthermore, shear wave elastography (SWE) is able to monitor reduced tumor stiffness caused by tranilast-micelles and predict response to nano-immunotherapy. Micellar encapsulation is a promising strategy for TME-reprogramming and SWE is a potential biomarker of response.<\/jats:p>","DOI":"10.1038\/s41467-022-34744-1","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T10:17:34Z","timestamp":1669198654000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":123,"title":["Polymeric micelles effectively reprogram the tumor microenvironment to potentiate nano-immunotherapy in mouse breast cancer models"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6256-3250","authenticated-orcid":false,"given":"Myrofora","family":"Panagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fotios","family":"Mpekris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrysovalantis","family":"Voutouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9828-8203","authenticated-orcid":false,"given":"John D.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Hiroi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippos","family":"Demetriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chryso","family":"Pierides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Stylianou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeto","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi","family":"Georgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Papageorgis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petri Ch.","family":"Papaphilippou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Koumas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Costeas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genichiro","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4030-2631","authenticated-orcid":false,"given":"Horacio","family":"Cabral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3093-1696","authenticated-orcid":false,"given":"Triantafyllos","family":"Stylianopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,22]]},"reference":[{"key":"34744_CR1","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1056\/NEJMoa1809615","volume":"379","author":"P Schmid","year":"2018","unstructured":"Schmid, P. et al. Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer. N. Engl. J. Med. 379, 2108\u20132121 (2018).","journal-title":"N. Engl. J. Med."},{"key":"34744_CR2","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1001\/jamaoncol.2018.5152","volume":"5","author":"S Adams","year":"2019","unstructured":"Adams, S. et al. Atezolizumab plus nab-paclitaxel in the treatment of metastatic triple-negative breast cancer with 2-year survival follow-up: a phase 1b clinical trial. JAMA Oncol. 5, 334\u2013342 (2019).","journal-title":"JAMA Oncol."},{"key":"34744_CR3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41571-019-0308-z","volume":"17","author":"JD Martin","year":"2020","unstructured":"Martin, J. D., Cabral, H., Stylianopoulos, T. & Jain, R. K. Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges. Nat. Rev. Clin. Oncol. 17, 251\u2013266 (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"34744_CR4","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nrclinonc.2010.139","volume":"7","author":"RK Jain","year":"2010","unstructured":"Jain, R. K. & Stylianopoulos, T. Delivering nanomedicine to solid tumors. Nat. Rev. Clin. Oncol. 7, 653\u2013664 (2010).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"34744_CR5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.trecan.2018.02.005","volume":"4","author":"T Stylianopoulos","year":"2018","unstructured":"Stylianopoulos, T., Munn, L. L. & Jain, R. K. Reengineering the physical microenvironment of tumors to improve drug delivery and efficacy: from mathematical modeling to bench to bedside. Trends Cancer 4, 292\u2013319 (2018).","journal-title":"Trends Cancer"},{"key":"34744_CR6","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1146\/annurev-physiol-020518-114700","volume":"81","author":"JD Martin","year":"2019","unstructured":"Martin, J. D., Seano, G. & Jain, R. K. Normalizing function of tumor vessels: progress, opportunities, and challenges. Annu. Rev. Physiol. 81, 505\u2013534 (2019).","journal-title":"Annu. Rev. Physiol."},{"key":"34744_CR7","doi-asserted-by":"publisher","first-page":"15101","DOI":"10.1073\/pnas.1213353109","volume":"109","author":"T Stylianopoulos","year":"2012","unstructured":"Stylianopoulos, T. et al. Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors. Proc. Natl Acad. Sci. USA 109, 15101\u201315108 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"34744_CR8","doi-asserted-by":"crossref","unstructured":"Nia, H. T., Munn, L. L. & Jain, R. K. Physical traits of cancer. Science 370, eaaz0868 (2020).","DOI":"10.1126\/science.aaz0868"},{"key":"34744_CR9","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.1016\/j.jbiomech.2014.09.019","volume":"47","author":"C Voutouri","year":"2014","unstructured":"Voutouri, C. & Stylianopoulos, T. Evolution of osmotic pressure in solid tumors. J. Biomech. 47, 3441\u20133447 (2014).","journal-title":"J. Biomech."},{"key":"34744_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fonc.2018.00055","volume":"8","author":"M Kalli","year":"2018","unstructured":"Kalli, M. & Stylianopoulos, T. Defining the role of solid stress and matrix stiffness in cancer cell proliferation and metastasis. Front. Oncol. 8, 55 (2018).","journal-title":"Front. Oncol."},{"key":"34744_CR11","doi-asserted-by":"publisher","first-page":"e0193801","DOI":"10.1371\/journal.pone.0193801","volume":"13","author":"C Voutouri","year":"2018","unstructured":"Voutouri, C. & Stylianopoulos, T. Accumulation of mechanical forces in tumors is related to hyaluronan content and tissue stiffness. PLoS ONE 13, e0193801 (2018).","journal-title":"PLoS ONE"},{"key":"34744_CR12","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.1158\/0008-5472.CAN-12-4521","volume":"73","author":"T Stylianopoulos","year":"2013","unstructured":"Stylianopoulos, T. et al. Coevolution of solid stress and interstitial fluid pressure in tumors during progression: implications for vascular collapse. Cancer Res. 73, 3833\u20133841 (2013).","journal-title":"Cancer Res."},{"key":"34744_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ccr.2014.06.003","volume":"26","author":"VP Chauhan","year":"2014","unstructured":"Chauhan, V. P. et al. Compression of pancreatic tumor blood vessels by hyaluronan is caused by solid stress and not interstitial fluid pressure. Cancer Cell 26, 14\u201315 (2014).","journal-title":"Cancer Cell"},{"key":"34744_CR14","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1126\/science.1171362","volume":"324","author":"KP Olive","year":"2009","unstructured":"Olive, K. P. et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324, 1457\u20131461 (2009).","journal-title":"Science"},{"key":"34744_CR15","doi-asserted-by":"publisher","unstructured":"Chauhan, V. P. et al. Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels. Nat. Commun. 4, https:\/\/doi.org\/10.1038\/ncomms.3516 (2013).","DOI":"10.1038\/ncomms.3516"},{"key":"34744_CR16","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/d41587-019-00019-2","volume":"37","author":"C Sheridan","year":"2019","unstructured":"Sheridan, C. Pancreatic cancer provides testbed for first mechanotherapeutics. Nat. Biotechnol. 37, 829\u2013831 (2019).","journal-title":"Nat. Biotechnol."},{"key":"34744_CR17","doi-asserted-by":"publisher","first-page":"e1730","DOI":"10.1002\/wnan.1730","volume":"13","author":"JD Martin","year":"2021","unstructured":"Martin, J. D., Miyazaki, T. & Cabral, H. Remodeling tumor microenvironment with nanomedicines. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol 13, e1730 (2021).","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol"},{"key":"34744_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/srep46140","volume":"7","author":"P Papageorgis","year":"2017","unstructured":"Papageorgis, P. et al. Tranilast-induced stress alleviation in solid tumors improves the efficacy of chemo- and nanotherapeutics in a size-independent manner. Sci. Rep. 7, 46140 (2017).","journal-title":"Sci. Rep."},{"key":"34744_CR19","doi-asserted-by":"publisher","first-page":"24506","DOI":"10.18632\/oncotarget.15534","volume":"8","author":"C Polydorou","year":"2017","unstructured":"Polydorou, C., Mpekris, F., Papageorgis, P., Voutouri, C. & Stylianopoulos, T. Pirfenidone normalizes the tumor microenvironment to improve chemotherapy. Oncotarget 8, 24506\u201324517 (2017).","journal-title":"Oncotarget"},{"key":"34744_CR20","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1073\/pnas.1018892108","volume":"108","author":"B Diop-Frimpong","year":"2011","unstructured":"Diop-Frimpong, B., Chauhan, V. P., Krane, S., Boucher, Y. & Jain, R. K. Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors. Proc. Natl Acad. Sci. USA 108, 2909\u20132914 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"34744_CR21","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1073\/pnas.1818357116","volume":"116","author":"Y Zhao","year":"2019","unstructured":"Zhao, Y. et al. Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma. Proc. Natl Acad. Sci. USA 116, 2210\u20132219 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"34744_CR22","doi-asserted-by":"crossref","unstructured":"Voutouri, C. et al. Endothelin inhibition potentiates cancer immunotherapy revealing mechanical biomarkers predictive of response. Adv. Therapeutics 4, 2000289 (2021).","DOI":"10.1002\/adtp.202000289"},{"key":"34744_CR23","doi-asserted-by":"publisher","first-page":"6396","DOI":"10.1021\/acsnano.8b07865","volume":"13","author":"JD Martin","year":"2019","unstructured":"Martin, J. D. et al. Dexamethasone increases cisplatin-loaded nanocarrier delivery and efficacy in metastatic breast cancer by normalizing the tumor microenvironment. ACS Nano 13, 6396\u20136408 (2019).","journal-title":"ACS Nano"},{"key":"34744_CR24","doi-asserted-by":"publisher","first-page":"4558","DOI":"10.1073\/pnas.1815515116","volume":"116","author":"IX Chen","year":"2019","unstructured":"Chen, I. X. et al. Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer. Proc. Natl Acad. Sci. USA 116, 4558\u20134566 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"34744_CR25","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.7150\/thno.36936","volume":"10","author":"M Panagi","year":"2020","unstructured":"Panagi, M. et al. TGF-beta inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunity. Theranostics 10, 1910\u20131922 (2020).","journal-title":"Theranostics"},{"key":"34744_CR26","first-page":"2001917","volume":"8","author":"F Mpekris","year":"2021","unstructured":"Mpekris, F. et al. Normalizing the microenvironment overcomes vessel compression and resistance to nano-immunotherapy in breast cancer lung metastasis. Adv. Sci. (Weinh.) 8, 2001917 (2021).","journal-title":"Adv. Sci. (Weinh.)"},{"key":"34744_CR27","unstructured":"Martin, J. D. et al. A microenvironment normalizing schedule of dexamethasone potentiates immune checkpoint blockade in metastatic murine cancer. Under review (2020)."},{"key":"34744_CR28","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1001\/jamaoncol.2019.0892","volume":"5","author":"JE Murphy","year":"2019","unstructured":"Murphy, J. E. et al. Total neoadjuvant therapy with FOLFIRINOX in combination with losartan followed by chemoradiotherapy for locally advanced pancreatic cancer: a phase 2 clinical trial. JAMA Oncol. 5, 1020\u20131027 (2019).","journal-title":"JAMA Oncol."},{"key":"34744_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/10837450.2016.1265553","volume":"23","author":"T Xia","year":"2018","unstructured":"Xia, T. et al. Losartan loaded liposomes improve the antitumor efficacy of liposomal paclitaxel modified with pH sensitive peptides by inhibition of collagen in breast cancer. Pharm. Dev. Technol. 23, 13\u201321 (2018).","journal-title":"Pharm. Dev. Technol."},{"key":"34744_CR30","doi-asserted-by":"publisher","first-page":"10674","DOI":"10.1073\/pnas.1819889116","volume":"116","author":"VP Chauhan","year":"2019","unstructured":"Chauhan, V. P. et al. Reprogramming the microenvironment with tumor-selective angiotensin blockers enhances cancer immunotherapy. Proc. Natl Acad. Sci. USA 116, 10674\u201310680 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"34744_CR31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.molliq.2012.10.013","volume":"177","author":"O Topel","year":"2013","unstructured":"Topel, O., Cakir, B. A., Budama, L. & Hoda, N. Determination of critical micelle concentration of polybutadiene-block-poly(ethyleneoxide) diblock copolymer by fluorescence spectroscopy and dynamic light scattering. J. Mol. Liq. 177, 40\u201343 (2013).","journal-title":"J. Mol. Liq."},{"key":"34744_CR32","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1248\/cpb.c20-00289","volume":"68","author":"GL See","year":"2020","unstructured":"See, G. L., Arce, F. Jr, Itakura, S., Todo, H. & Sugibayashi, K. Prolonged distribution of tranilast in the eyes after topical application onto eyelid skin. Chem. Pharm. Bull. (Tokyo) 68, 779\u2013783 (2020).","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"34744_CR33","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1113\/expphysiol.1987.sp003085","volume":"72","author":"JR Levick","year":"1987","unstructured":"Levick, J. R. Flow through interstitium and other fibrous matrices. Q J. Exp. Physiol. Cms 72, 409\u2013438 (1987).","journal-title":"Q J. Exp. Physiol. Cms"},{"key":"34744_CR34","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-bioeng-071813-105259","volume":"16","author":"RK Jain","year":"2014","unstructured":"Jain, R. K., Martin, J. D. & Stylianopoulos, T. The role of mechanical forces in tumor growth and therapy. Annu. Rev. Biomed. Eng. 16, 321\u2013346 (2014).","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"34744_CR35","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jconrel.2022.03.008","volume":"345","author":"F Mpekris","year":"2022","unstructured":"Mpekris, F. et al. Normalizing tumor microenvironment with nanomedicine and metronomic therapy to improve immunotherapy. J. Control Release 345, 190\u2013199 (2022).","journal-title":"J. Control Release"},{"key":"34744_CR36","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/nnano.2011.166","volume":"6","author":"H Cabral","year":"2011","unstructured":"Cabral, H. et al. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat. Nanotechnol. 6, 815\u2013823 (2011).","journal-title":"Nat. Nanotechnol."},{"key":"34744_CR37","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nnano.2012.45","volume":"7","author":"VP Chauhan","year":"2012","unstructured":"Chauhan, V. P. et al. Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner. Nat. Nanotechnol. 7, 383\u2013388 (2012).","journal-title":"Nat. Nanotechnol."},{"key":"34744_CR38","doi-asserted-by":"publisher","first-page":"18632","DOI":"10.1073\/pnas.1318415110","volume":"110","author":"T Stylianopoulos","year":"2013","unstructured":"Stylianopoulos, T. & Jain, R. K. Combining two strategies to improve perfusion and drug delivery in solid tumors. Proc. Natl Acad. Sci. USA 110, 18632\u201318637 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"34744_CR39","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s10637-016-0422-z","volume":"35","author":"H Mukai","year":"2017","unstructured":"Mukai, H. et al. A first-in-human Phase 1 study of epirubicin-conjugated polymer micelles (K-912\/NC-6300) in patients with advanced or recurrent solid tumors. Invest N. Drugs 35, 307\u2013314 (2017).","journal-title":"Invest N. Drugs"},{"key":"34744_CR40","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jconrel.2018.10.035","volume":"292","author":"T Chida","year":"2018","unstructured":"Chida, T. et al. Epirubicin-loaded polymeric micelles effectively treat axillary lymph nodes metastasis of breast cancer through selective accumulation and pH-triggered drug release. J. Control Release 292, 130\u2013140 (2018).","journal-title":"J. Control Release"},{"key":"34744_CR41","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1126\/science.aaw7875","volume":"365","author":"LL Munn","year":"2019","unstructured":"Munn, L. L. & Jain, R. K. Vascular regulation of antitumor immunity. Science 365, 544\u2013545 (2019).","journal-title":"Science"},{"key":"34744_CR42","doi-asserted-by":"crossref","unstructured":"Stylianopoulos, T. The solid mechanics of cancer and strategies for improved therapy. J. Biomech. Eng. 139, 021004 (2017).","DOI":"10.1115\/1.4034991"},{"key":"34744_CR43","first-page":"3077","volume":"30","author":"K Izumi","year":"2010","unstructured":"Izumi, K. et al. Preliminary results of tranilast treatment for patients with advanced castration-resistant prostate cancer. Anticancer Res 30, 3077\u20133081 (2010).","journal-title":"Anticancer Res"},{"key":"34744_CR44","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1021\/acsnano.8b06164","volume":"13","author":"X Liu","year":"2019","unstructured":"Liu, X. et al. Improved efficacy and reduced toxicity using a custom-designed irinotecan-delivering silicasome for orthotopic colon cancer. ACS Nano 13, 38\u201353 (2019).","journal-title":"ACS Nano"},{"key":"34744_CR45","doi-asserted-by":"publisher","first-page":"10127","DOI":"10.1021\/acsnano.0c03386","volume":"14","author":"H Kinoh","year":"2020","unstructured":"Kinoh, H. et al. Translational nanomedicine boosts anti-PD1 therapy to eradicate orthotopic PTEN-negative glioblastoma. ACS Nano 14, 10127\u201310140 (2020).","journal-title":"ACS Nano"},{"key":"34744_CR46","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1093\/oncolo\/oyac155","volume":"27","author":"RF Riedel","year":"2022","unstructured":"Riedel, R. F. et al. Results of NC-6300 (Nanoparticle Epirubicin) in an expansion cohort of patients with angiosarcoma. Oncologist 27, 809\u2013e765 (2022).","journal-title":"Oncologist"},{"key":"34744_CR47","doi-asserted-by":"publisher","first-page":"11960","DOI":"10.1021\/acsomega.9b01228","volume":"4","author":"BJR Moore","year":"2019","unstructured":"Moore, B. J. R. et al. Repurposing of tranilast for potential neuropathic pain treatment by inhibition of sepiapterin reductase in the BH4 pathway. ACS Omega 4, 11960\u201311972 (2019).","journal-title":"ACS Omega"},{"key":"34744_CR48","doi-asserted-by":"publisher","first-page":"110136","DOI":"10.1016\/j.ejrad.2021.110136","volume":"147","author":"S Flogstad Svensson","year":"2022","unstructured":"Flogstad Svensson, S. et al. Decreased tissue stiffness in glioblastoma by MR elastography is associated with increased cerebral blood flow. Eur. J. Radio. 147, 110136 (2022).","journal-title":"Eur. J. Radio."},{"key":"34744_CR49","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jconrel.2017.04.033","volume":"258","author":"S Quader","year":"2017","unstructured":"Quader, S. et al. cRGD peptide-installed epirubicin-loaded polymeric micelles for effective targeted therapy against brain tumors. J. Control Release 258, 56\u201366 (2017).","journal-title":"J. Control Release"},{"key":"34744_CR50","doi-asserted-by":"crossref","unstructured":"Panagi, M. et al. Polymeric micelles effectively reprogram tumor microenvironment to potentiate nano-immunotherapy in mouse breast cancer models. Zenodo https:\/\/zenodo.org\/record\/7151427#.Y1ovY3bMKUk (2022).","DOI":"10.1038\/s41467-022-34744-1"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34744-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34744-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34744-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T19:00:08Z","timestamp":1669230008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34744-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["34744"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-34744-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,22]]},"assertion":[{"value":"8 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7165"}}